Loading...
XHKG
0775
Market cap711mUSD
Jul 09, Last price  
0.58HKD
1D
-3.33%
1Q
-21.62%
Jan 2017
-15.94%
IPO
-68.97%
Name

CK Life Sciences Intl (Holdings) Inc

Chart & Performance

D1W1MN
XHKG:0775 chart
P/E
P/S
1.03
EPS
Div Yield, %
Shrs. gr., 5y
0.04%
Rev. gr., 5y
1.82%
Revenues
5.41b
-2.04%
2,197,118,0002,091,592,0002,991,797,0002,678,889,0002,694,204,0003,511,563,0004,545,022,0004,970,927,0004,954,043,0004,919,309,0004,868,540,0004,693,133,0005,232,992,0004,967,024,0004,942,544,0005,402,312,0005,275,590,0005,322,733,0005,522,674,0005,410,228,000
Net income
-188m
L+48.91%
102,022,000117,001,000-351,768,000187,098,000208,551,000125,826,000176,331,000229,008,000263,558,000284,912,000251,971,000258,402,000263,001,000181,735,000125,234,000162,801,000131,963,00017,250,000-126,554,000-188,447,000
CFO
-33m
L
159,233,000213,000-22,818,000149,674,000167,174,000121,512,000435,403,000267,056,000324,523,000303,707,000438,914,000134,568,000230,692,000379,147,000530,955,000423,575,000363,659,000514,181,000353,534,000-32,772,000
Dividend
May 23, 20230.008 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related and Health. The company was founded on August 10, 2001 and is headquartered in Hong Kong.
IPO date
Jul 16, 2002
Employees
1,887
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT